Real-world (rw) treatment (tx) patterns and overall survival (OS) in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) treated with avelumab first-line maintenance (1LM): Updated results from the SPEAR Bladder II study.
| Autor: | Bupathi, Manojkumar, Sura, Sneha, Ike, Chiemeka, Morris, Valerie A., Conkling, Paul R., Todoroff, Karen, Bhanegaonkar, Abhijeet |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p393-393, 13p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|